共 50 条
- [22] PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction [J]. BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1129):
- [25] TREATMENT RESPONSE EVALUATION USING 18F-FET PET IN GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE TREATED WITH A COMBINATION OF BEVACIZUMAB PLUS LOMUSTINE [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 125 - 125
- [26] The Role of Metabolic Parameters of Pre-treatment 18F-FDG PET/CT in Patients with Locally Advanced Cervical Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E497 - E498
- [29] Textural and Conventional Pretherapeutic [18F]FDG PET/CT Parameters for Survival Outcome Prediction in Stage III and IV Oropharyngeal Cancer Patients [J]. APPLIED SCIENCES-BASEL, 2024, 14 (04):
- [30] Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4677 - 4691